DISHMAN CARBOGEN AMCIS
Back to Cashflow Statement
|
DISHMAN CARBOGEN AMCIS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-102 Cr | ₹-22 Cr | ₹250 Cr | ₹130 Cr | ₹-11 Cr |
What is the latest Cash Flow from Financing Activities ratio of DISHMAN CARBOGEN AMCIS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-102 Cr |
| Mar2024 | ₹-22 Cr |
| Mar2023 | ₹250 Cr |
| Mar2022 | ₹130 Cr |
| Mar2021 | ₹-11 Cr |
How is Cash Flow from Financing Activities of DISHMAN CARBOGEN AMCIS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-102 Cr | Negative | |
| Mar2024 | ₹-22 Cr | Negative | |
| Mar2023 | ₹250 Cr | 91.52 | |
| Mar2022 | ₹130 Cr | Positive | |
| Mar2021 | ₹-11 Cr | - | |
Compare Cash Flow from Financing Activities of peers of DISHMAN CARBOGEN AMCIS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DISHMAN CARBOGEN AMCIS | ₹4,453.1 Cr | 2.2% | -7.4% | 52.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,791.0 Cr | 1.2% | 4.2% | -10.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,885.0 Cr | -0.5% | 8.9% | 10.8% | Stock Analytics | |
| CIPLA | ₹127,930.0 Cr | 0.4% | 3.7% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,108.0 Cr | -0% | -2.1% | 6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,164.0 Cr | 2.2% | -1.8% | -4.4% | Stock Analytics | |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DISHMAN CARBOGEN AMCIS | 2.2% |
-7.4% |
52.5% |
| SENSEX | 0.9% |
2.5% |
3.7% |
You may also like the below Video Courses